SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

An initial misreport of Webull's earnings per share sparked controversy and accusations of manipulation, yet bulls highlight strong revenue growth and record customer assets against persistent concerns over dilution.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining significant attention as NVIDIA's deepening engagement with photonics underscores the critical demand for advanced optical interconnects in AI data centers. The community is eagerly awaiting potential game-changing news from the upcoming OFC conference, where POET's innovative technology is expected to be a highlight.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is a hot topic following an earnings report that highlighted a revenue miss and widened losses, intensifying debate over its significant market valuation compared to current financials. This is contrasted by community discussion around recent achievements in gate fidelity and government contracts, positioning the company as a key player in the emerging sovereign quantum era.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending following a massive insider share purchase by CEO Jeff Green, signaling strong executive confidence. This, alongside widespread rumors of an OpenAI partnership for ad sales, is sparking community speculation about a potential short squeeze for the recently oversold stock.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following strong Q4 earnings, which marked a significant swing to profitability, and upcoming presentations of positive long-term data for its pipeline asset, navenibart. The community is actively debating whether these strong fundamentals and pipeline potential will finally overcome persistent short interest and lead to a re-rating of the stock's perceived undervaluation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as its latest earnings report showcases remarkable growth in AI semiconductor sales and a strong outlook with AI chip revenue projected to exceed $100 billion by 2027, sparking fervent community discussion about its market position and potential for continued upside in the competitive chip sector.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is trending as it touches multi-year lows following a sector-wide slump driven by General Mills' cautious outlook and ongoing analyst downgrades. However, community discussions are sharply divided, with some viewing it as a deeply undervalued defensive play with strong dividend appeal, anticipating significant upside from potential tariff relief and strategic brand performance despite concerns over debt and margin compression.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta's Q4 earnings surpassed expectations, but weaker Q1 guidance has sparked a mixed market reaction; community discussion centers on whether Wall Street is overlooking the company's strong full-year outlook and its strategic positioning to secure human and emerging AI identities.

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Veeva Systems Inc - Ordinary Shares - Class A

Veeva Systems is trending after reporting strong Q4 earnings and providing robust FY27 guidance, leading to a significant surge in trading volume and largely bullish community sentiment. Investors are actively discussing the company's AI initiatives as a key driver for future growth and efficiency within the life sciences sector.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending as investors grapple with an unconfirmed earnings date and recent leadership changes within its key Qwen AI division, alongside a quickly retracted U.S. Pentagon designation. The community is sharply divided, with many frustrated by persistent weakness and China's evolving economic policy, while others see the stock as oversold and poised for a rebound driven by its AI advancements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO

Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - AGIO Levi & Korsinsky Reminds Agios Pharmaceuticals, Inc...

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO

Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact The Gross Law Firm Regarding Potential Securities Law Violations - AGIO Agios Pharmaceuticals, Inc...

Agios Pharmaceuticals Teases 2026 Catalysts as PYRUKYND Thalassemia Launch Gains Early Traction

Agios Pharmaceuticals (NASDAQ:AGIO) executives highlighted multiple upcoming clinical and regulatory milestones during the 46th Annual TD Cowen Healthcare Conference, while also discussing early...

Vanguard Group Inc. Sells 77,143 Shares of Agios Pharmaceuticals, Inc. $AGIO

Vanguard Group Inc. trimmed its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 1.4% during the 3rd quarter, according to its most recent 13F filing with the...

Erste Asset Management GmbH Purchases 438,411 Shares of Agios Pharmaceuticals, Inc. $AGIO

Erste Asset Management GmbH lifted its position in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 18.8% in the 3rd quarter, according to its most recent 13F filing with the SEC...

Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Passes Below Two Hundred Day Moving Average - Should You Sell?

Agios Pharmaceuticals (NASDAQ:AGIO) Share Price Crosses Below 200 Day Moving Average - Time to Sell...

From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer

Key PointsCommodore Capital sold 2,338,287 shares of Agios Pharmaceuticals in the fourth quarter...

Eagle Health Investments LP Sells 84,600 Shares of Agios Pharmaceuticals, Inc. $AGIO

Eagle Health Investments LP trimmed its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) by 25.6% in the 3rd quarter, according to its most recent disclosure with the SEC...

Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash

Key PointsRock Springs Capital Management sold 159,379 Agios Pharmaceuticals shares in the fourth quarter; the estimated trade size was $5.59 million based on average fourth-quarter prices...

HC Wainwright Issues Positive Estimate for AGIO Earnings

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO - Free Report) - HC Wainwright boosted their Q1 2026 earnings per share (EPS) estimates for Agios Pharmaceuticals in a report issued on Thursday, February...

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

AGIO
Agios Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest AGIO News

AGIOAgios Pharmaceuticals Inc